Hot Features
プレミアム
Acadia Pharmaceuticals Inc (ACAD)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Ms. Laura A. BregeIndependent Director | 8.11k | 0.00 | Derivative Exercise and Retained Stock | - | 23.20k | 53.71% |
| 2026-05-29 | Mr. James M. DalyIndependent Director | 8.11k | 0.00 | Derivative Exercise and Retained Stock | - | 12.15k | 200.62% |
| 2026-05-29 | Dr. Edmund P. HarriganIndependent Director | 8.11k | 0.00 | Derivative Exercise and Retained Stock | - | 43.15k | 23.14% |
| 2026-05-29 | Mr. Jonathan M. PooleIndependent Director | 2.01k | 0.00 | Derivative Exercise and Retained Stock | - | 2.01k | - |
| 2026-05-29 | Dr. Elizabeth A. GarofaloIndependent Director | 8.11k | 0.00 | Derivative Exercise and Retained Stock | - | 33.49k | 31.94% |
| 2026-05-29 | Dr. Adora NduIndependent Director | 8.11k | 0.00 | Derivative Exercise and Retained Stock | - | 32.91k | 32.69% |
| 2026-05-01 | Mr. Mark C. SchneyerExec. VP & CFO | 3.31k | 0.00 | Derivative Exercise and Retained Stock | - | 66.15k | 5.27% |
| 2026-05-01 | Mr. Mark C. SchneyerExec. VP & CFO | -3.51k | 76.40k | Derivative Exercise and Sale | 21.79 | 66.15k | - |
| 2026-05-01 | Mr. James K. KiharaSVP of Finance | 1.26k | 0.00 | Derivative Exercise and Retained Stock | - | 29.13k | 4.54% |
| 2026-05-01 | Mr. James K. KiharaSVP of Finance | -1.33k | 29.02k | Derivative Exercise and Sale | 21.79 | 29.13k | - |
| 2026-04-05 | Mr. Mark C. SchneyerExec. VP & CFO | 2.57k | 0.00 | Derivative Exercise and Retained Stock | - | 62.84k | 4.26% |
| 2026-04-05 | Mr. Mark C. SchneyerExec. VP & CFO | -2.71k | 60.14k | Derivative Exercise and Sale | 22.20 | 62.84k | - |
| 2026-04-05 | Mr. James K. KiharaSVP of Finance | 980.00 | 0.00 | Derivative Exercise and Retained Stock | - | 27.87k | 3.65% |
| 2026-04-05 | Mr. James K. KiharaSVP of Finance | -1.03k | 22.87k | Derivative Exercise and Sale | 22.20 | 27.87k | - |
| 2026-03-24 | Mr. James K. KiharaSVP of Finance | 1.83k | 0.00 | Derivative Exercise and Retained Stock | - | 26.89k | 7.29% |
| 2026-03-24 | Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary | -3.84k | 82.53k | Derivative Exercise and Sale | 21.47 | 11.28k | - |
| 2026-03-24 | Mr. Mark C. SchneyerExec. VP & CFO | -7.39k | 159.14k | Derivative Exercise and Sale | 21.47 - 21.72 | 60.27k | - |
| 2026-03-24 | Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary | 3.67k | 0.00 | Derivative Exercise and Retained Stock | - | 11.28k | 48.25% |
| 2026-03-24 | Mr. Mark C. SchneyerExec. VP & CFO | 6.93k | 0.00 | Derivative Exercise and Retained Stock | - | 60.27k | 12.99% |
| 2026-03-24 | Ms. Catherine E. Owen AdamsCEO & Director | -11.64k | 249.93k | Derivative Exercise and Sale | 21.47 | 14.80k | - |
| 2026-03-24 | Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development | -3.44k | 73.75k | Derivative Exercise and Sale | 21.47 | 3.28k | - |
| 2026-03-24 | Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development | 3.28k | 0.00 | Derivative Exercise and Retained Stock | - | 3.28k | - |
| 2026-03-24 | Mr. James K. KiharaSVP of Finance | -1.94k | 41.90k | Derivative Exercise and Sale | 21.47 - 21.73 | 26.89k | - |
| 2026-03-24 | Ms. Catherine E. Owen AdamsCEO & Director | 11.87k | 0.00 | Derivative Exercise and Retained Stock | - | 14.80k | 404.36% |
| 2026-02-06 | Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary | 5.99k | 0.00 | Derivative Exercise and Retained Stock | - | 7.61k | 371.15% |
| 2026-02-06 | Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary | -6.95k | 162.49k | Derivative Exercise and Sale | 23.38 | 7.61k | - |
| 2025-11-17 | Mr. Mark C. SchneyerExec. VP & CFO | 9.56k | 0.00 | Derivative Exercise and Retained Stock | - | 53.34k | 21.85% |
| 2025-11-17 | Mr. Mark C. SchneyerExec. VP & CFO | -10.26k | 243.11k | Derivative Exercise and Sale | 23.69 | 53.34k | - |
| 2025-11-17 | Mr. James K. KiharaSVP of Finance | 3.85k | 0.00 | Derivative Exercise and Retained Stock | - | 25.06k | 18.14% |
| 2025-11-17 | Mr. James K. KiharaSVP of Finance | -4.08k | 96.75k | Derivative Exercise and Sale | 23.69 | 25.06k | - |
| 2025-11-10 | Mr. James M. DalyIndependent Director | -30.00k | 670.98k | 売り | 22.37 | 4.04k | -88.13% |
| 2025-09-15 | Mr. Mark C. SchneyerExec. VP & CFO | -3.50k | 82.73k | Automatic Disposition | 23.65 | 43.45k | -7.45% |
| 2025-09-02 | Dr. Elizabeth A. GarofaloIndependent Director | -1.60k | 41.56k | 売り | 25.98 | 25.38k | -5.93% |
| 2025-08-18 | Mr. Mark C. SchneyerExec. VP & CFO | -22.00k | 554.02k | Automatic Disposition | 25.18 | 40.13k | -35.41% |
| 2025-06-04 | Ms. Laura A. BregeIndependent Director | -14.45k | 314.63k | 売り | 21.78 | 15.10k | -48.90% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
